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Rosacea is a common and chronic inflammatory skin
disease most frequently seen in groups of genetically
related individuals. Although the symptoms of rosa-
cea are heterogeneous, they are all related by the
presence of characteristic facial or ocular inflamma-
tion involving both the vascular and tissue stroma.
Until recently, the pathophysiology of this disease was
limited to descriptions of a wide variety of factors that
exacerbate or improve disease. Recent molecular
studies show a common link between the triggers of
rosacea and the cellular response, and these observa-
tions suggest that an altered innate immune response
is involved in disease pathogenesis. Understanding
rosacea as a disorder of innate immunity explains the
benefits of current treatments and suggests new
therapeutic strategies for alleviating this disease.
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INTRODUCTION
As the phenotypes of rosacea are clinically heterogeneous,
rosacea studies were diversely conducted based on the
clinical manifestations, histology, and factors exacerbating
the skin disorder. From these diverse findings, the pathology
of rosacea was thought to be ‘unknown’ and was expected to
be caused by multiple factors. Emotional stress, spicy food,
hot beverages, alcohol consumption, high environmental
temperatures, sun exposure, and menopause exacerbate the
rosacea symptoms such as erythema, rash, and telangiectasia
(Crawford et al., 2004; Buechner, 2005). For example, studies
have shown increased density of mites in patients with
rosacea compared with control patients (Bonnar et al., 1993;
Forton and Seys, 1993; Erbagci and Ozgoztasi, 1998), a
controversial correlation of Helicobacter pylori infection and
rosacea (Rebora et al., 1994; Jones et al., 1998; Szlachcic,
2002; Argenziano et al., 2003; Diaz et al., 2003), as well
as other varied potential microbial triggers. These findings
implied that the external environment would affect rosacea,
but is not sufficient or specific to the disease. In the other
words, specific intrinsic factors in the host that recognizes
and responds to the diverse environmental triggers must be
key to understanding the pathogenesis of rosacea.
We recently reported findings of a common aberrant
innate immune response in rosacea that when triggered in
mice could reproduce characteristic aspects of the human
disease (Yamasaki et al., 2007). This article discusses the
possible pathophysiology of rosacea through the window of
the innate immune system.
ABERRANT CATHELICIDIN EXPRESSION IN ROSACEA
SKIN
Strong experimental data from both mice and human tissues
have led us to hypothesize that a dysregulation of the innate
immune system in patients with rosacea could unify current
clinical observations. In innate immunity, the pattern
recognition system, which includes the Toll-like receptor
(TLR) families, respond to environmental stimuli such as UV,
microbes, physical, and chemical trauma. Triggering the
innate immune system normally leads to a controlled
increase in cytokines and antimicrobial molecules in the
skin (Takeda et al., 2003; Meylan et al., 2006). One of these
antimicrobial molecules is a peptide known as cathelicidin
(Dorschner et al., 2001), the first antimicrobial peptide
discovered in mammalian skin (Gallo et al., 1994). Cathe-
licidin is barely detectable in granular to cornified layers of
normal skin, and is greatly induced by the skin wounding and
infection to protect the damaged epidermis from microbe
invasion (Nizet et al., 2001). Some forms of cathelicidin
peptides have a unique capacity to be both vasoactive and
proinflammatory (Koczulla et al., 2003; Braff et al., 2005).
Therefore, given the potential for a single molecule to affect
both of the vascular and inflammatory events that define
rosacea, we began an analysis of cathelicidin in affected
patients compared with matched controls. Individuals with
rosacea expressed abnormally high levels of cathelicidin in
epidermis (Yamasaki et al., 2007). Importantly, the cathe-
licidin peptide forms found in rosacea were not only more
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abundant but were also of different molecular weights
compared with those in normal individuals. These forms of
cathelicidin peptides promote and regulate leukocyte che-
motaxis (De et al., 2000), angiogenesis (Koczulla et al.,
2003), and expression of extracellular matrix components
(Gallo et al., 1994), whereas the types most commonly found
on normal skin function mostly as antibiotics and have little
to no action in inflammation (Murakami et al., 2004; Braff
et al., 2005). One of the most common forms of cathelicidin
found in rosacea is LL-37 (Yamasaki et al., 2007). This
cathelicidin is typically present in neutrophils recruited to
infected or injured skin; however, in the case of rosacea
patients LL-37 appears to be generated in the epidermis by an
abnormal action of serine proteases. When LL-37 is applied
in animal models, it was found to be a potent angiogenic
factor and resulted in neovascularization in a rabbit model of
hind-limb ischemia (Koczulla et al., 2003). Angiogenesis by
LL-37 is mediated by formyl peptide receptor-like 1, a
G-protein-coupled receptor expressed on endothelial cells
(Koczulla et al., 2003). LL-37 also transactivates epidermal
growth factor receptor and downstream signaling in epithelial
cells (Tjabringa et al., 2003; Tokumaru et al., 2005), and
epidermal growth factor receptor signaling induces vascular
endothelial growth factor in epidermal keratinocytes (Detmar
et al., 1994). Thus, LL-37 induces endothelial cell changes
through several signaling pathways, and is a common
explanation for vascular effects.
To confirm the importance of these observations in
rosacea skin and test the hypothesis that abnormal cathe-
licidin could induce the signs of rosacea, we injected these
peptides or the enzymes that produce cathelicidin into the
skin of mice. This rapidly resulted in skin inflammation
resembling pathological changes in rosacea (Yamasaki et al.,
2007). Combined, these findings indicated that an exacer-
bated innate immune response induces abnormal cathelici-
din, and that this then leads to the clinical findings, therefore
confirming our hypothesis.
ROSACEA SKIN INCREASES ACTIVITY OF KALLIKREIN 5,
A CATHELICIDIN-PROCESSING SERINE PROTEASE
The presence of the vasoactive and inflammatory cathelicidin
peptides in rosacea was subsequently explained by abnormal
production of local serine protease kallikrein 5 (KLK5, also
know as stratum corneum tryptic enzyme), which processes
cathelicidin peptides from a precursor protein in the
epidermis (Yamasaki et al., 2006). Entire epidermis of rosacea
skin shows increased expression of KLK5 and subsequently
high protease activity (Yamasaki et al., 2007). Interestingly,
mouse skin lacking lympho-epithelial kazal type-related
inhibitor, the intrinsic inhibitor of KLK5, also shows high
protease activity and high cathelicidin peptide production
(Yamasaki et al., 2007). Similarly, when active human
KLK5 was injected into mouse skin, cathelicidin processing
increased and was accompanied by skin inflammation. This
did not occur if the proteolytic activity of KLK5 was destroyed
by heating the enzyme before injection. Combined, these
multiple lines of experimental evidence in animal models
suggested that the abnormally high protease activity found in
rosacea patients results in processing forms of cathelicidin
peptides to peptides that induce the characteristic inflamma-
tion and vascular changes of this disease.
ALTERED TOLL-LIKE RECEPTOR 2 EXPRESSION IN
ROSACEA
A critical question remains as to why individuals prone to
rosacea react with high KLK5 and cathelicidin. A potential
explanation for this response can be found by understanding
that the innate immune system of the skin is programmed to
detect microbes, tissue damage such as UV-induced apopto-
sis, or damage of the extracellular matrix (Chen et al., 2007;
Taylor et al., 2007). Among multiple detection systems, TLRs
are an abundant and powerful mechanism that widely
recognizes microbe derivatives and induces cellular responses
such as cytokines and antimicrobial peptides. In the skin of
individuals with rosacea, TLR2 was recently found to be more
highly expressed compared with that of non-affected indivi-
duals (Yamasaki et al., 2011). Increased TLR2 enhances skin
susceptibility to specific environmental stimuli and leads to
increased cathelicidin production. Cathelicidin transcription
in epidermal keratinocytes is also regulated by the active form
of vitamin D 1,25(OH)2D3 (Schauber et al., 2006). TLR2
stimulation amplifies this by increasing the enzymatic conver-
sion of 25(OH)D3 to active 1,25(OH)2D3 (Liu et al., 2006;
Schauber et al., 2007). Thus, human epidermal keratinocytes
can produce more 1,25(OH)2D3 locally by TLR2 stimuli, and
this in turn enables the epidermis to produce cathelicidin
antimicrobial peptides. KLK5 mRNA transcription is also
increased by 1,25(OH)2D3 keratinocytes (Morizane et al.,
2010). Evidence supporting this conclusion was obtained by
genetic overexpression of TLR2 with a TLR2-expressing vector,
or testing the response of mice with a knockout of the TLR2
gene. In these situations, it was found that increasing or
stimulating TLR2 increased KLK5, whereas knocking out TLR2
decreased KLK5 (Yamasaki et al., 2011). These findings
therefore suggest that the increase of TLR2 in rosacea skin
makes the skin of these patients susceptible to microbes and
environmental stimuli, therefore resulting in the high cathe-
licidin and KLK5 expressions, which drive the disease.
Interestingly, TLR2 involvement has also been suggested
in other dermatoses resembling rosacea. Glucocorticoid-
induced rosacea-like dermatitis, so-called perioral dermatitis,
includes erythema, pustules, and papules somewhat similar to
that seen in rosacea. Although the precise molecular mechan-
isms of the steroid-induced dermatitis is not determined, Shibata
et al. (2009) reported that glucocorticoids increase TLR2
expression in epidermal keratinocytes. They also showed that
Propionibacterium acnes enhanced glucocorticoid-dependent
TLR2 induction, which was abolished by RU486, a glucocorti-
coid receptor antagonist (Shibata et al., 2009). P. acnes is
known to activate TLR2 and induce inflammatory cytokines in
acne (Kim et al., 2002). Furthermore, the clinical benefits of
retinoic acid for rosacea and acne could be partially explained
by the ability of retinoic acid to decrease TLR2 expression and
function (Liu et al., 2005). Thus, these new findings and
accumulated knowledge on rosacea and related dermatoses
suggest that TLR2 has a role in disease pathogenesis.
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Honoring the memory of Dr Albert Kligman, an article on
Demodex folliculorum, a mite that lives within sebaceous
follicles, was the subject of a recent commentary in this
journal (Kligman and Christensen, 2011). As discussed in the
article, Demodex has been implicated as a trigger of rosacea
as histological studies revealed inflammation of the pilose-
baceous follicle units, and studies have shown increased
density of the mites in patients with rosacea compared with
control patients (Bonnar et al., 1993; Forton and Seys, 1993;
Erbagci and Ozgoztasi, 1998). Lacey et al. (2007) isolated
Bacillus oleronius from D. folliculorum and identified the
antigens reacting to sera from rosacea individuals but not
from control individuals. Extracts of B. oleronius stimulate
proliferation of mononuclear cells from patients with rosacea,
suggesting that individuals with rosacea are exposed to
B. oleronius from D. folliculorum. Interestingly, they identi-
fied heat-shock proteins and a lipoprotein in the antigenic
molecules of B. oleronius. Heat-shock protein and lipo-
proteins are known to be stimulants for TLR2 (Costa et al.,
2002; Gobert et al., 2004). Therefore, reports of triggers
for rosacea from microbes associated with Demodex are
entirely consistent with the conclusion that an abnormally
reactive innate immune system is the basis for the patho-
physiology of rosacea.
SUMMARY
Understanding the role of cathelicidin in promotion of
inflammation and vascular responses in rosacea provides a
molecular insight into this disease. The factors that promote
clinical exacerbation of the disease also promote production
of critical innate immune molecules that serve to connect
molecular observations with the characteristic cellular obser-
vations of rosacea (Figure 1). Genetic susceptibility within
certain human ethnic groups probably reflects a specific
innate immune response programmed within these patients,
which makes them more susceptible to certain stimuli.
Although much work needs to be done, these new associa-
tions give us clues to further our understanding of the
mechanisms responsible for the disease and of strategies for
the optimal treatment.
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Figure 1. Molecular mechanisms for the pathogenesis of rosacea. Rosacea
skin is susceptible to environmental changes, altered hormone balance,
and microbe challenges because of increased Toll-like receptor 2 (TLR2).
The activation of TLR2 then induces an increase in effector molecules:
cathelicidin and kallikrein 5 (KLK5). Elevated KLK5 results in generation
of active peptides such as LL-37. This peptide stimulates vascular changes
and inflammatory cell recruitment. CAMP, cathelicidin antimicrobial peptide.
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